Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at EMSELEX udviste en virkning, der svarer til virkningen af andre antikolinerge midler, som bruges ved overaktiv blære - syndrom.
The Committee for Medicinal Products for Human Use (CHMP) concluded that EMSELEX showed an effectiveness similar to that of other anticholinergic medicines used in overactive bladder syndrome.